To: Personnel File From: Jonathan M. Rothberg, Chairman of the Board, CEO and President Date: February 1, 2005 Re: Amendment to Employment Agreement dated April 1, 2002Curagen Corp • May 5th, 2005 • Services-commercial physical & biological research
I, Jonathan M. Rothberg, (“the Executive”) signed an Employment Agreement (“the Agreement”) with my employer, CuraGen Corporation (“the Company”), on or about April 1, 2002, and subsequently signed an Addendum to the Agreement on October 31, 2003. Exhibit A, Item 1) of the original Agreement provides that the Executive’s initial base salary shall be subject to increases by the Board of Directors, which shall review the salary periodically. Therefore, pursuant to the minutes of the January 25, 2005, Meeting of the Compensation Committee of the Board of Directors, the Executive’s 2005 base salary will be adjusted to $420,000 per year, payable in bi-weekly installments.
To: Personnel File From: Christopher K. McLeod, Interim CEO & President of 454 Life Sciences Corporation Date: February 1, 2005 Re: Amendment to Employment Agreement dated April 1, 2002Employment Agreement • May 5th, 2005 • Curagen Corp • Services-commercial physical & biological research
I, Christopher K. McLeod, (“the Executive”) signed an Employment Agreement (“the Agreement”) with my employer, CuraGen Corporation (“the Company”), on or about April 1, 2002, and subsequently signed an Addendum to the Agreement on October 31, 2003. Exhibit A, Item 1) of the original Agreement provides that the Executive’s initial base salary shall be subject to increases by the Board of Directors, which shall review the salary periodically. Therefore, pursuant to the minutes of the January 25, 2005, Meeting of the Compensation Committee of the Board of Directors, the Executive’s 2005 base salary was adjusted to $286,000 per year, payable in bi-weekly installments. However, effective January 31, 2005, as a result of being named Interim CEO & President of 454 Life Sciences Corporation the Executive’s base salary was increased to $322,000, which is payable in bi-weekly installments.
To: Personnel File From: Timothy M. Shannon, EVP & Chief Medical Officer Date: February 1, 2005 Re: Amendment to Employment Agreement dated September 9, 2002Curagen Corp • May 5th, 2005 • Services-commercial physical & biological research
I, Timothy M. Shannon, (“the Executive”) signed an Employment Agreement (“the Agreement”) with my employer, CuraGen Corporation (“the Company”), on or about September 9, 2002, and subsequently signed an Addendum to the Agreement on October 31, 2003. Exhibit A, Item 1) of the original Agreement provides that the Executive’s initial base salary shall be subject to increases by the Board of Directors, which shall review the salary periodically. Therefore, pursuant to the minutes of the January 25, 2005, Meeting of the Compensation Committee of the Board of Directors, the Executive’s 2005 base salary will be adjusted to $310,000 per year, payable in bi-weekly installments.
February 10, 2005 Richard F. Begley, Ph.D. Guilford, CT 06437 Re: Separation Agreement Dear Dick:Letter Agreement • May 5th, 2005 • Curagen Corp • Services-commercial physical & biological research • Connecticut
The purpose of this letter agreement (the “Agreement”) is to set forth the terms of your separation from 454 Life Sciences Corporation (the “Company”), a Delaware corporation. Payment of the Separation Benefits (defined below) is contingent on your agreement to and compliance with the terms of this Agreement, as set forth below.
To: Personnel File From: David M. Wurzer, EVP & Chief Financial Officer Date: February 1, 2005 Re: Amendment to Employment Agreement dated April 1, 2002Curagen Corp • May 5th, 2005 • Services-commercial physical & biological research
I, David M. Wurzer, (“the Executive”) signed an Employment Agreement (“the Agreement”) with my employer, CuraGen Corporation (“the Company”), on or about April 1, 2002, and subsequently signed an Addendum to the Agreement on October 31, 2003. Exhibit A, Item 1) of the original Agreement provides that the Executive’s initial base salary shall be subject to increases by the Board of Directors, which shall review the salary periodically. Therefore, pursuant to the minutes of the January 25, 2005, Meeting of the Compensation Committee of the Board of Directors, the Executive’s 2005 base salary will be adjusted to $286,000 per year, payable in bi-weekly installments.
